HeartSciences (HSCS) Net Cash Flow (QoQ) (2021 - 2025)
HeartSciences (HSCS) Net Cash Flow (QoQ) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn |
| 10 | HeartSciences | 6.45 Mn | 4.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -149.65% |
| Jul 31, 2025 | 213.06% |
| Apr 30, 2025 | -2.94% |
| Jan 31, 2025 | -406.02% |
| Oct 31, 2024 | 80.40% |
| Jul 31, 2024 | -15.69% |
| Apr 30, 2024 | -118.19% |
| Jan 31, 2024 | 1,567.13% |
| Oct 31, 2023 | 56.17% |
| Jul 31, 2023 | -301.06% |
| Apr 30, 2023 | 76.38% |
| Jan 31, 2023 | 4.31% |
| Oct 31, 2022 | -135.67% |
| Jul 31, 2022 | 918.21% |
| Apr 30, 2022 | -142.80% |
| Jan 31, 2022 | 224.71% |
| Oct 31, 2021 | -7.05% |